Document is current
Any future updates will be listed below
-
Authors
Pecci-Terroba, Clara https://orcid.org/0000-0002-6379-582X
Lai, Meng-Chuan https://orcid.org/0000-0002-9593-5508
Lombardo, Michael V. https://orcid.org/0000-0001-6780-8619
Chakrabarti, Bhismadev https://orcid.org/0000-0002-6649-7895
Ruigrok, Amber N. V. https://orcid.org/0000-0001-7711-8056
Suckling, John https://orcid.org/0000-0002-5098-1527
Anagnostou, Evdokia https://orcid.org/0000-0002-3455-9887
Lerch, Jason P. https://orcid.org/0000-0001-6164-2881
Taylor, Margot J. https://orcid.org/0000-0002-3534-9750
Nicolson, Rob https://orcid.org/0000-0001-7086-7038
Georgiades, Stelios
Crosbie, Jennifer https://orcid.org/0000-0002-8710-3322
Schachar, Russell https://orcid.org/0000-0002-2015-4395
Kelley, Elizabeth https://orcid.org/0000-0001-7742-6542
Jones, Jessica https://orcid.org/0000-0002-1116-4321
Arnold, Paul D. https://orcid.org/0000-0003-2496-4624
Seidlitz, Jakob https://orcid.org/0000-0002-8164-7476
Alexander-Bloch, Aaron F. https://orcid.org/0000-0001-6554-1893
Bullmore, Edward T. https://orcid.org/0000-0002-8955-8283
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
Bedford, Saashi A. https://orcid.org/0000-0002-0491-5342
Bethlehem, Richard A. I. https://orcid.org/0000-0002-0714-0685
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 14 May 2025
First Online: 4 June 2025
Declarations
:
: Ethical approval and informed consent were obtained for each primary study. The Cambridge Psychology Research Ethics Committee (PRE.2020.104) deemed that secondary analysis of deidentified data did not require ethical oversight.
: Not applicable.
: RAIB, MVL, and M-CL are Associate Editors, and EA and BC are Editorial Board members of Molecular Autism. SBC is a former Editor-in-Chief of the journal. ETB reports consultancy work for Boehringer Ingelheim, Sosei Heptares, SR One, and GlaxoSmithKline. ETB, RAIB, JS, and AFA-B are cofounders of Centile Bioscience. PDA receives research support from Biohaven Pharmaceuticals. M-CL has received editorial honorarium from SAGE Publications. RN reported receiving grants from Brain Canada, Hoffman La Roche, Otsuka Pharmaceuticals, and Maplight Therapeutics outside the submitted work. EA reported receiving grants from Roche and Anavex; receiving nonfinancial support from AMO Pharma and CRA-Simons Foundation; and receiving personal fees from Roche, Impel, Ono, and Quadrant outside the submitted work.
